Hemorheological and Glycemic Parameters and HDL Cholesterol for the Prediction of Cardiovascular Events

Sung Woo Cho1, Byung Gyu Kim1, Byung Ok Kim1

  • 1College of Medicine, Inje University, Seoul, Korea.

Insights

Erythrocyte sedimentation rate (ESR), fibrinogen, and high-density lipoprotein (HDL) cholesterol are key predictors of major adverse cardiovascular events (MACE) and coronary heart disease (CHD). These hemorheological and lipid parameters, along with glycemic control, offer valuable insights into cardiovascular risk in outpatients.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Chemistry
  • Epidemiology

Background:

  • Biomarkers such as hemorheological parameters, glycemic status, and high-density lipoprotein (HDL) cholesterol are crucial for assessing atherosclerosis and thrombosis risk.
  • Understanding the interplay of these markers is vital for predicting cardiovascular outcomes.

Purpose of the Study:

  • To evaluate the association and clinical significance of erythrocyte sedimentation rate (ESR), fibrinogen, fasting glucose, glycated hemoglobin (HbA1c), and HDL cholesterol.
  • To determine their predictive value for major adverse cardiovascular events (MACE) and coronary heart disease (CHD) in an outpatient setting.

Main Methods:

  • A cohort of 708 stable outpatients was followed for a mean of 28.5 months.
  • Patients were categorized based on the occurrence of MACE (cardiac death, myocardial infarction, newly diagnosed CHD, cerebral vascular accident).
  • Hemorheological, glycemic, and lipid profiles were compared between groups.

Main Results:

  • Patients with MACE exhibited higher ESR, fibrinogen, fasting glucose, and HbA1c, alongside lower HDL cholesterol compared to those without MACE.
  • Elevated ESR and fibrinogen, and low HDL cholesterol significantly predicted MACE risk in multivariate analysis.
  • High fibrinogen and HbA1c levels were associated with increased risk of multivessel CHD, and ESR/fibrinogen correlated with HbA1c and HDL cholesterol.

Conclusions:

  • Hemorheological abnormalities, poor glycemic control (high HbA1c), and low HDL cholesterol are interconnected.
  • These factors serve as effective surrogate markers for predicting MACE and CHD in outpatient populations.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
742
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
812
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K